Molecular Imaging
Sophisticated cancer detection innovation
Cyclomedica's Molecular Imaging division was established mid 2006. This division aims to:
operate PET central pharmacies in Australia to produce sterile, injectable, unit PET doses or molecular biomarkers.
provide diagnositic imaging services such as Macquarie Medical Imaging.
provide PET equipment; cyclotrons, synthesisers, dispensers and associated products necessary to operate PET central pharmacies in Asia Pacific excluding North America. This equipment is sourced under an exclusive licence from Cyclopharma Laboratoires SA, a leading European molecular imaging company.
